Stem Cells and Liver Replacement;Stammzellen und Leberersatz

Medizinische Klinik

Volumn 98, Issue SUPPL. 2, 2003, Pages 18-22

  Fändrich, Fred ^a   Ruhnke, Maren ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Dedifferentiation; Differentiation; Liver; Monocyte; Programmability; Stem cell

Indexed keywords

CELL DIFFERENTIATION; COST BENEFIT ANALYSIS; DEGENERATION; EMBRYO CELL; EMBRYO DEVELOPMENT; ETHICS; GENETIC DISORDER; GERM LAYER; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; OUTCOMES RESEARCH; PARAMETER; PLASTICITY; PLURIPOTENT STEM CELL; REVIEW; RISK ASSESSMENT; STEM CELL; TISSUE INJURY;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; FEMALE; FORECASTING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOCYTES; HISTOCOMPATIBILITY ANTIGENS; HUMANS; LIVER DISEASES; LIVER REGENERATION; MALE; MICE; MICE, KNOCKOUT; MONOCYTES; RATS; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0346494349     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Surami AM. Reprogramming of genome function through epigenetic inheritance. Nature 2001;414:122-8.
2. Spemann H, Mangold H. Induction of embryonic primordia by implantation of organizers from a different species. 1923. Int J Dev Biol 2001;45:13-38.
3. Bird AP, Woffe AP. Methylation-induced repression-belts, braces and chromatin. Cell 1999;99:451-4.
4. Rideout WM, Eggan K, Jaenisch R. Nuclear cloning and epigenetic reprogramming of the genome. Science 2001;293:1093-8.
5. Hochedlinger K, Jaenisch R. Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. N Engl j Med 2003;349:275-86
6. Forbes SJ, Vig P, Poulsom R, et al. Adult stem cell plasticity: new pathways of tissue regeneration become visible. Clin Sci (Colch) 2002;103:355-69.
7. Hochedlinger K, Jaenisch R. Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature 2002;415:1035-8.
8. Rosenthal N. Prometheus's vulture and the stem-cell promise. N Engl J Med 2003;349:267-74.
9. Velloso CP, Simon A, Brockes JP. Mammalian postmitotic nuclei reenter the cell cycle alter serum stimulation in newt/mouse hybrid myotubes. Curr Biol 2001;11:855-8.
10. Lo DC, Allen F, Brockes JP. Reversal of muscle differentiation during urodele limb regeneration. Proc Natl Acad Sci U S A 1993;90:7230-4.
11. Tanaka EM, Gann AA, Gates PB, et al. Newt myotubes re-enter the cell cycle by phosphorylation of the retinoblastoma protein. J Cell Biol 1997;136:155-65.
12. Solter D. Mammalian cloning: advances and limitations. Nat Rev Genet 2001;1:199-207.
13. Hochedlinger K, Jaenisch R. Nuclear transplantation: lessons from frogs and mice. Curr Opin Cell Biol 2002;14:741-8.
14. Eggan K, Akutsu H, Loring J, et al. Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc Natl Acad Sci U S A 2001;98:6209-14.
15. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-9.
16. Schwartz RE, Keyes M, Koodie L, et al. Multipotent adult progenitor cells from bone marrow differentate into functional hepatocyte-like cells. J Clin Invest 2002;109:1291-302.
17. Willer K, Brown JD, Danenberg E, et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 2003;423:448-52.
18. Grompe M. Therapeutic liver repopulation for the treatment of metabolic liver diseases. Hum Cell 1999;12:171-80
19. Overturf, Al-Dhalimy M, Finegold M, et al. The repopulation of hepatocyte populations differing in size and prior mitotic expansion. Am J Pathol 1999;155:2135-43.
20. Fox IJ, Chowdhury, Kaufman SS, et al. Treatment of the Crigler-Najjar syndrome type 1 with hepatocyte transplantation. N Engl J Med 1998;338:1422-6.
21. Grossman M, Raper SE, Kozarsky K, et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolemia. Nat Genet 1994;6:335-41.
22. Grome M, Lindstedt S, Al-Dhalimy M, et al. Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I. Nat Genet 1995;10:453-60.
23. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000;6:1229-34.
24. Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999;284:1168-70.
25. Theise N, Badve S, Saxena R, et al. Liver from bone marrow in humans. Hepatology 2000;32:11-6.
26. Kleeberger W, Rothamel T, Glockner S, et al. High frequency of epithelial chimerism in liver transplants demonstrated by microdissection and STR-analysis. Hepatology 2002;35:110-6.
27. Laconi E, Oren R, Mukhopadhyay DK, et al. Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol 1998;153:319-29.